The glycolyzer: Automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery
- 20 August 2012
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 12 (15-16), 2523-2538
- https://doi.org/10.1002/pmic.201100273
Abstract
Human serum glycomics is a promising method for finding cancer biomarkers but often lacks the tools for streamlined data analysis. The Glycolyzer software incorporates a suite of analytic tools capable of identifying informative glycan peaks out of raw mass spectrometry data. As a demonstration of its utility, the program was used to identify putative biomarkers for epithelial ovarian cancer from a human serum sample set. A randomized, blocked, and blinded experimental design was used on a discovery set consisting of 46 cases and 48 controls. Retrosynthetic glycan libraries were used for data analysis and several significant candidate glycan biomarkers were discovered via hypothesis testing. The significant glycans were attributed to a glycan family based on glycan composition relationships and incorporated into a linear classifier motif test. The motif test was then applied to the discovery set to evaluate the disease state discrimination performance. The test provided strongly predictive results based on receiver operator characteristic curve analysis. The area under the receiver operator characteristic curve was 0.93. Using the Glycolyzer software, we were able to identify a set of glycan biomarkers that highly discriminate between cases and controls, and are ready to be formally validated in subsequent studies.Keywords
Funding Information
- National Institute of Health (RO1 GM049077)
- National Ovarian Cancer Coalition
- Sacramento Chapter
This publication has 57 references indexed in Scilit:
- Human Serum Processing and Analysis Methods for Rapid and Reproducible N-Glycan Mass ProfilingJournal of Proteome Research, 2010
- Chip-based Reversed-phase Liquid Chromatography−Mass Spectrometry of Permethylated N-Linked Glycans: A Potential Methodology for Cancer-biomarker DiscoveryAnalytical Chemistry, 2010
- Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic massAmerican Journal of Obstetrics and Gynecology, 2010
- Glycomic Analysis of Sialic Acid Linkages in Glycans Derived from Blood Serum GlycoproteinsJournal of Proteome Research, 2010
- Glycomics and disease markersCurrent Opinion in Chemical Biology, 2009
- The development of retrosynthetic glycan libraries to profile and classify the human serum N‐linked glycomeProteomics, 2009
- Profile of native N‐linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time‐of‐flight mass spectrometryProteomics, 2009
- Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry dataBioinformatics, 2008
- Glycoproteomics for Prostate Cancer Detection: Changes in Serum PSA Glycosylation PatternsJournal of Proteome Research, 2008
- Alterations in the Serum Glycome Due to Metastatic Prostate CancerJournal of Proteome Research, 2007